Detection of an IDH mutation in a diffuse astrocytic glioma with microvascular proliferation or necrosis is no longer compatible with a glioblastoma diagnosis, i.e., such tumors are now diagnosed as astrocytoma, IDH-mutant, CNS WHO grade 4 [7, 30]. The gene discussed is IDH2; the disease is glioblastoma.